HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM

Area of Science:

• Immunogenetics
• Molecular Biology
• Human Genetics

Background:

• Insulin-dependent diabetes mellitus (IDDM) has a complex genetic component.
• Human Leukocyte Antigen (HLA) genes, particularly HLA-DQ beta, are implicated in IDDM susceptibility.
• Understanding the specific polymorphisms within HLA-DQ beta is crucial for elucidating IDDM pathogenesis.

Purpose of the Study:

• To investigate the role of HLA-DQ beta nucleotide sequence polymorphism in IDDM genetic susceptibility.
• To determine the correlation between specific amino acid residues at position 57 of the DQ beta-chain and IDDM risk.
• To identify potential interactions between HLA-DQ beta and HLA-DR beta alleles in IDDM susceptibility.

Main Methods:

• DNA amplification using polymerase chain reaction (PCR).
• Sequencing of HLA-DQ beta gene fragments.
• Oligonucleotide hybridization for polymorphism analysis.
• Analysis of DNA from HLA-DR-typed IDDM patients and control subjects.

Main Results:

• A general correlation exists between the amino acid residue at position 57 of the DQ beta-chain and IDDM susceptibility.
• Presence of Aspartic acid (Asp) at position 57 is associated with lower susceptibility, while Alanine (Ala), Valine (Val), or Serine (Ser) are linked to higher susceptibility.
• Exceptions were observed in heterozygous IDDM patients and some Chinese IDDM patients, indicating that position-57 correlations are not absolute.
• Susceptibility in some heterozygous patients correlated with specific DR beta alleles (Dw4) rather than DQ beta alleles.

Conclusions:

• While the residue at position 57 of the DQ beta-chain generally correlates with IDDM susceptibility, it does not confer complete resistance.
• Specific combinations of HLA-DQ beta and HLA-DR beta sequences likely confer IDDM susceptibility.
• Further research into combined HLA haplotype analysis is warranted to fully understand IDDM genetic predisposition.